◀ Back to AKT1
AKT1 — CD79A
Text-mined interactions from Literome
Li et al., Proc Natl Acad Sci U S A 1999
:
In this study, we demonstrate that ligation of
B cell antigen receptor (BCR) leads to activation of
Akt/PKB in B lymphocytes ... In this study, we demonstrate that ligation of
B cell antigen receptor (BCR) leads to activation of
Akt/PKB in B lymphocytes ...
BCR induced
activation of
Akt/PKB required the tyrosine kinase Syk, which was not previously known to regulate Akt/PKB ...
BCR induced
activation of
Akt/PKB required the tyrosine kinase Syk, which was not previously known to regulate Akt/PKB ... Our results show that Lyn provides a mechanism for negative regulation and opposes the effect of Syk on
BCR mediated activation of
Akt/PKB ... Our results show that Lyn provides a mechanism for negative regulation and opposes the effect of Syk on
BCR mediated activation of
Akt/PKB
Astoul et al., J Cell Biol 1999
:
Membrane translocation of PKB and subsequent
PKB activation are
dependent on
BCR activation of phosphatidylinositol 3-kinase (PI3K)
Craxton et al., J Biol Chem 1999
:
Increased
BCR induced
Akt phosphorylation was observed in Lyn-deficient DT40 cells and Lyn ( -/- ) mice compared with wild-type cells suggesting that Lyn may negatively regulate Akt function
Voss et al., Oncogene 2000
(MAP Kinase Signaling System...) :
The mitogenic MAPK/Erk kinases as well as
Akt/PKB , a kinase implicated to negatively regulate apoptosis, were also constitutively
activated by both
Bcr-Abl and Tel-Abl ... The mitogenic MAPK/Erk kinases as well as
Akt/PKB , a kinase implicated to negatively regulate apoptosis, were also constitutively
activated by both
Bcr-Abl and Tel-Abl
Christian et al., J Biol Chem 2003
:
Consistent with the idea that Rap-GTP is a negative regulator of the PI3K/Akt pathway, expressing constitutively active Rap2 ( Rap2V12 ) reduced
BCR induced phosphorylation of
Akt and FKHR
Kövesdi et al., Cell Signal 2004
(MAP Kinase Signaling System) :
We have detected a short lived
BCR-driven activation of mitogen activated protein kinases ( ERK1/2 and p38 MAPK ) and
Akt/PKB in transitional immature B cells that correlated with the lack of c-Fos expression, reduced phosphorylation of Akt substrates and a susceptibility for apoptosis
Tybulewicz et al., Eur J Immunol 2004
(Second Messenger Systems) :
Unexpectedly, they show that while the
BCR induced phosphorylation of the PI3K dependent kinase
Akt is reduced in p85alpha-deficient cells, the phosphorylation of two downstream targets of Akt -- FOXO1 and ribosomal protein S6 -- is largely unaffected
Barnes et al., Oncogene 2005
(Leukemia, Myelogenous, Chronic, BCR-ABL Positive) :
Both IL-3 treatment and expression of
Bcr-Abl led to enhanced phosphorylation of
Akt ( protein kinase B )
Xing et al., J Exp Med 2005
:
G5pr(-/-) B cells did not show abnormalities in the
BCR mediated
activation of Erks and NF-kappaB, cyclin D2 induction, or
Akt activation
Bilancio et al., Blood 2006
:
p110delta activity is indispensable for
BCR induced DNA synthesis and phosphorylation of
Akt/protein kinase B (PKB) , forkhead transcription factor/forkhead box O3a (FOXO3a), and p70 S6 kinase (p70 S6K), with modest effects on the phosphorylation of glycogen synthase kinase 3 alpha/beta ( GSK3alpha/beta ) and extracellular signal regulated kinase ( Erk ) ... p110delta activity is indispensable for
BCR induced DNA synthesis and phosphorylation of
Akt/protein kinase B (PKB), forkhead transcription factor/forkhead box O3a (FOXO3a), and p70 S6 kinase (p70 S6K), with modest effects on the phosphorylation of glycogen synthase kinase 3 alpha/beta ( GSK3alpha/beta ) and extracellular signal regulated kinase ( Erk )
Chu et al., Cancer Res 2007
(Cell Transformation, Neoplastic...) :
BCR/ABL expression
results in enhanced Ras and
Akt activity but reduced mitogen activated protein kinase activity in human hematopoietic cells, which is reversed by BCR/ABL-Y177 mutation
Lee et al., Journal of cell communication and signaling 2007
:
In contrast,
BCR induced
activation of ERK, JNK, p38, and
Akt was not affected by ROS depletion
Gobessi et al., Leukemia 2009
(Leukemia, Lymphocytic, Chronic, B-Cell) :
In addition, R406 prevented the increase in leukemic cell viability induced by sustained BCR engagement and inhibited
BCR induced
Akt activation and Mcl-1 upregulation
Hirano et al., J Biol Chem 2009
(Leukemia, Myelogenous, Chronic, BCR-ABL Positive) :
Thus,
Bcr-Abl represses the expression of PHLPP1 and PHLPP2 and continuously
activates Akt1 , -2, and -3 via phosphorylation on Ser-473, resulting in the proliferation of CML cells
Quiroga et al., Blood 2009
(Leukemia, Lymphocytic, Chronic, B-Cell) :
Finally, R406 inhibited constitutive and
BCR induced
activation of Syk, extracellular signal regulated kinases, and
AKT , and blocked BCR induced calcium mobilization
Oak et al., Autoimmunity 2009
:
BCR mediated
AKT phosphorylation is partially reduced in p85alpha-deficient B cells and further diminished with concomitant loss of p85beta
Taniguchi et al., PloS one 2013
:
Here, we present data indicating that the increase in intracellular zinc level induced by ZIP9/SLC39A9 ( a ZIP Zrt-/Irt-like protein ) plays an important role in the activation of
Akt and Erk in
response to
BCR activation